Evidence map›Paper›PMID 34358546›Full record

ReviewJournal of molecular biology2022

Chemical Modulation of Gasdermin-Mediated Pyroptosis and Therapeutic Potential.

Christopher B Ryder, Hannah C Kondolf, Meghan E O'Keefe, Bowen Zhou, Derek W Abbott

Open access · greenAbstract readReview
In one paragraph

Review in Journal of molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Post-translational control of NLRP3 inflammasome signaling.The Journal of biological chemistry · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Gasdermin-B Pro-Tumor Function in Novel Knock-in Mouse Models Depends on theFrontiers in cell and developmental biology · 2022
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Christopher B RyderDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio 44106, USA.
Hannah C KondolfDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.
Meghan E O'KeefeDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.
Bowen ZhouDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.
Derek W AbbottDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA. Electronic address: dwa4@case.edu.
University School · USUniversity Hospitals of Cleveland · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Molecular mechanisms of gasdermin recognition by proteases and autophagy proteins in cytokine releaseP01AI141350 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ABBOTT, DEREK W · 2020 to 2024
$9.4M
Immunology Training Program-PredoctoralT32AI089474 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI COBB, BRIAN A · 2010 to 2025
$3.4M
Innate Immune Signal Transduction Specificity in Inflammatory DiseaseR35GM141603 · NIGMS · NATIONAL JEWISH HEALTH · PI Derek W Abbott · 2021 to 2026
$1.9M
NIAID NIH HHS P01 AI141350NIAID NIH HHS T32 AI089474NIGMS NIH HHS R35 GM141603NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

Pyroptosis, a lytic form of programmed cell death, both stimulates effective immune responses and causes tissue damage. Gasdermin (GSDM) proteins are a family of pore-forming executors of pyroptosis. While the most-studied member, GSDMD, exerts critical functions in inflammasome biology, emerging evidence demonstrates potential broad relevance for GSDM-mediated pyroptosis across diverse pathologies. In this review, we describe GSDM biology, outline conditions where inflammasomes and GSDM-mediated pyroptosis represent rational therapeutic targets, and delineate strategies to manipulate these central immunologic processes for the treatment of human disease.

Indexed as

InflammasomesMolecular Targeted TherapyPhosphate-Binding ProteinsPore Forming Cytotoxic ProteinsPyroptosisGasderminsHumansGasderminsGSDMD protein, humanInflammasomesPhosphate-Binding ProteinsPore Forming Cytotoxic Proteinsanti-tumor immunityimmunogenic cell deathinflammasomeinflammasomopathypore-forming protein

Identifiers

PMID34358546
PMCPMC8810912
OpenAlexW3192952564

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.